Table 1

Baseline Patient Characteristics (N = 57)

Male34 (60.0)
Age, yrs57 ± 9
BMI (kg/m2)29 ± 5
Paroxysmal AF50 (88.0)
Months from first AF episode57 (36–120)
Concomitant cardiovascular disease
 Heart failure2 (4.0)
 Hypertension24 (42.0)
 Diabetes2 (4.0)
 Coronary artery disease1 (2.0)
 Valvular heart disease1 (2.0)
 Stroke/TIA8 (14.0)
CHA2DS2-VASc scores
 015 (26.0)
 120 (35.0)
 ≥222 (39.0)
Medications
 Beta-blockers37 (65.0)
 Class I AADs16 (28.0)
 Class III AADs16 (28.0)
 Warfarin42 (74.0)

Values are n (%), mean ± SD, or median (interquartile range).

AAD = antiarrhythmic drug; AF = atrial fibrillation; BMI = body mass index; CHA2DS2-VASc = congestive heart failure, hypertension, age ≥65 or 75 yrs, diabetes, prior stroke or transient ischemic attack, vascular disease, female sex; TIA = transient ischemic attack.